Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Pulmonary Structural and Functional MRI to Predict Exacerbations and Regional Disease Progression

FY 2024-25

Summary
Cystic fibrosis is a rare lung disease that disproportionately impacts healthcare systems due to the severe nature of the disease, its associated reduction in life expectancy, and how frequently patients require hospitalization. Although cutting-edge research has slowed the progression of cystic fibrosis, there is no cure. Lung infections, called exacerbations, are common in cystic fibrosis and cause damage that makes it easier for infections to re-occur, driving a cycle of lung health decline. Current cystic fibrosis management aims to monitor patients for signs of exacerbations to catch them early and minimize damage. A better goal is to predict where and when these exacerbations will occur to prevent the cycle of damage altogether, however current clinical tests lack the sensitivity needed to predict exacerbations. My research uses medical imaging, specifically magnetic resonance imaging, to see inside the lung and measure the changes associated with lung disease. Current lung tests examine how patients breathe to infer the health of the whole lung, but imaging presents an opportunity to examine the individual abnormalities causing symptoms at their source. We believe that the ability to detect individual lung changes like mucus-clogged airways will allow us to better understand how patients get sicker and predict which patients will experience exacerbations. Imaging detects not just who will get worse, but where they are getting worse, which we believe will open the door to new, localized therapies. My research aims to determine the specific changes to lung structure and function that precipitate damaging exacerbations. Cystic fibrosis presents a tremendous health burden to patients and their families, and an economic burden to Canada at large. We believe imaging can play an important role in lessening the costly healthcare burden, improving quality of life in people with cystic fibrosis, and extending the lives of those afflicted.
Program
Banting Postdoctoral Fellowship Program
Location
Ohio, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
511986
Name
Matheson Alexander
Region
Ohio
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Pulmonary Structural and Functional MRI to Predict Exacerbations and Regional Disease Progression
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Cystic Fibrosis; Disease Progression; Magnetic Resonance Imaging; Pulmonary Exacerbations; Pulmonary Imaging; Regional Analysis; Structure-Function Relationships
Abstract
Cystic fibrosis is a rare lung disease that disproportionately impacts healthcare systems due to the severe nature of the disease, its associated reduction in life expectancy, and how frequently patients require hospitalization. Although cutting-edge research has slowed the progression of cystic fibrosis, there is no cure. Lung infections, called exacerbations, are common in cystic fibrosis and cause damage that makes it easier for infections to re-occur, driving a cycle of lung health decline. Current cystic fibrosis management aims to monitor patients for signs of exacerbations to catch them early and minimize damage. A better goal is to predict where and when these exacerbations will occur to prevent the cycle of damage altogether, however current clinical tests lack the sensitivity needed to predict exacerbations. My research uses medical imaging, specifically magnetic resonance imaging, to see inside the lung and measure the changes associated with lung disease. Current lung tests examine how patients breathe to infer the health of the whole lung, but imaging presents an opportunity to examine the individual abnormalities causing symptoms at their source. We believe that the ability to detect individual lung changes like mucus-clogged airways will allow us to better understand how patients get sicker and predict which patients will experience exacerbations. Imaging detects not just who will get worse, but where they are getting worse, which we believe will open the door to new, localized therapies. My research aims to determine the specific changes to lung structure and function that precipitate damaging exacerbations. Cystic fibrosis presents a tremendous health burden to patients and their families, and an economic burden to Canada at large. We believe imaging can play an important role in lessening the costly healthcare burden, improving quality of life in people with cystic fibrosis, and extending the lives of those afflicted.
Competitiondate
202409
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Matheson, Alexander
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
Direct Payment - $140,000 Grant (2024-25) | Canada Spends